Molecular responses to tyrosine kinase inhibitors in rare, variant e1a2, e6a2 and e19a2 BCR-ABL chronic myeloid leukaemia

Typeset version

 

TY  - ABST
  - Abstract
  - Langabeer, SE,Crampe, M,McCarron, SL,Haslam, K,Connaghan, G,Perera, K,Cahill, MR,Conneally, E
  - 2010
  - January
  - Molecular responses to tyrosine kinase inhibitors in rare, variant e1a2, e6a2 and e19a2 BCR-ABL chronic myeloid leukaemia
  - Validated
  - 1
  - ()
  - 74
  - 74
DA  - 2010/01
ER  - 
@misc{V160750167,
   = {Abstract},
   = {Langabeer,  SE and Crampe,  M and McCarron,  SL and Haslam,  K and Connaghan,  G and Perera,  K and Cahill,  MR and Conneally,  E },
   = {2010},
   = {January},
   = {Molecular responses to tyrosine kinase inhibitors in rare, variant e1a2, e6a2 and e19a2 BCR-ABL chronic myeloid leukaemia},
   = {Validated},
   = {1},
   = {()},
  pages = {74--74},
  source = {IRIS}
}
OTHER_PUB_TYPEAbstract
AUTHORSLangabeer, SE,Crampe, M,McCarron, SL,Haslam, K,Connaghan, G,Perera, K,Cahill, MR,Conneally, E
YEAR2010
MONTHJanuary
TITLEMolecular responses to tyrosine kinase inhibitors in rare, variant e1a2, e6a2 and e19a2 BCR-ABL chronic myeloid leukaemia
RESEARCHER_ROLE
STATUSValidated
PEER_REVIEW1
TIMES_CITED()
SEARCH_KEYWORD
REFERENCE
ABSTRACT
PUBLISHER_LOCATION
PUBLISHER
EDITORS
ISBN_ISSN
EDITION
URL
START_PAGE74
END_PAGE74
DOI_LINK
FUNDING_BODY
GRANT_DETAILS